Patel Anish 4
4 · Enliven Therapeutics, Inc. · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Patel Anish
CHIEF OPERATING OFFICER
Transactions
- Sale
Common Stock
2025-12-08$20.76/sh−4,958$102,939→ 265,016 total(indirect: See footnote) - Sale
Common Stock
2025-12-08$21.78/sh−1,705$37,134→ 263,311 total(indirect: See footnote)
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust").
- [F2]This transaction was executed in multiple trades at prices ranging from $20.51 to $21.495. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]The shares are held by The Patel / Dong Family Trust.
- [F4]This transaction was executed in multiple trades at prices ranging from $21.51 to $22.055. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.